MedPath
HSA Approval

CLOPIDO TABLET 75 MG

SIN14410P

CLOPIDO TABLET 75 MG

CLOPIDO TABLET 75 MG

September 26, 2013

MD PHARMACEUTICALS PTE. LTD.

MD PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMD PHARMACEUTICALS PTE. LTD.
Licence HolderMD PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

B01AC04

clopidogrel

Manufacturer Information

MD PHARMACEUTICALS PTE. LTD.

Laboratorios Lesvi, S.L.

Active Ingredients

Clopidogrel bisulphate 97.86 mg eqv Clopidogrel

75 mg

Clopidogrel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CLOPIDO TABLET 75 MG - HSA Approval | MedPath